Deliberate AI

We're very excited to join the One Mind family and work together to improve mental health. Our CEO, Marc Aafjes, will join the kick-off of the One Mind Accelerator in the Bay Area this week.

?? Exciting news: $20M awarded to our world-class consortium, led by Mount Sinai Health System, to Transform Mental Healthcare through AI Innovation! We at Deliberate AI are thrilled to announce our participation in a word-class consortium (PREDiCTOR) led by the Mount Sinai Health System, in partnership with IBM Research, Harvard University, John Hopkins University, Columbia University, and Carnegie Mellon University. Our groundbreaking project has been awarded a $20 million grant from the National Institute of Mental Health (NIMH) as part of the IMPACT-MH initiative (Individually Measured Phenotypes to Advance Computational Translation in Mental Health) ?? PREDiCTOR is a significant stride toward validating our technology in clinical care, in addition to our breakthrough AI-COA (in FDA ISTAND, https://lnkd.in/gtRQw3-X) and biomarker work (e.g. DARPA-funded Suicide Prevention, https://lnkd.in/e-B2j7f7) . At Deliberate AI, we are dedicated to transcending traditional care paradigms to empower both clinicians and patients within the mental health space. Our purpose is rooted in three transformative shifts we're working on: Advanced Diagnostics and Monitoring, Ambient Clinical Intelligence, and Precision Therapy Enablement. This initiative will accelerate the journey toward a future where mental health care is proactive, personalized, and profoundly effective. ?? About PREDiCTOR: Mental healthcare faces significant challenges due to the lack of objective behavioral assessment tools leaving clinicians to rely on subjective impressions, limiting individualized prognoses and treatment plans. PREDiCTOR aims to change this by a step-change addition beyond the typical data captured in the electronic health record (EHR); tapping into ambient audiovisual data from clinical encounters (???: e.g., spoken language, eye contact, and facial expressions from patients and clinicians) and smartphone data (??: e.g., information on physical activity, geolocation, social interactions, and sleep patterns.) By fusing these data modalities using advanced AI and machine learning, and a large longitudinal transdiagnostic sample of over 2100, we aim to develop clinical signatures that predict key outcomes in young individuals aged 15 to 30, such as treatment engagement, emergency room visits, and hospitalizations. This work aligns with the Biden-Harris Administration's commitment to addressing the mental health crisis, and IMPACT-MH was highlighted in a recent announcement (https://lnkd.in/eesrkQ_3) by The White House. The recognition by the NIMH award underscores the national importance of our efforts. ?? We extend our deepest gratitude to our amazing partners and the community committed to improving mental health care. Together, we're paving the way for a brighter future for the next generation. #MentalHealthInnovation #AIforGood #YouthWellness #HealthcareTransformation #IMPACTMH #PREDiCTOR #EthicalAI

?? Exciting News! ?? We're thrilled to unveil our latest initiative: INSYTE Integrated Systems for Treatment Evaluation: a real world multimodal data collection effort led by physician scientists ?? Join us in building real-world datasets to guide evidence based practice and improve patient outcomes. Benefits for Clinicians: *Free access to the Deliberate platform for automated note transcription, PROs and beta testing cutting-edge AI outcome measures *Network and connect with other leaders in the field *Studies sponsored by the NIH, FDA and our industry partners Visit our website to learn more and sign up to stay updated on our progress. Plus, meet us at booth 506 at the APA Convention to learn more about INSYTE and our innovative solutions! https://lnkd.in/evFGxtiM #APAAM2024